drug
lorazepam ER
Marketedupdated 3mo agoby Almatica Pharma LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- drugLORAZEPAM12 co-mentions · 12 sources
- drugLorazepam Teva12 co-mentions · 12 sources
- tagApproval12 co-mentions · 6 sources
- tagSmall Molecule9 co-mentions · 7 sources
- tagRecall5 co-mentions · 5 sources
- companyLeading Pharma LLC3 co-mentions · 3 sources
- company$AMPHAmphastar Pharmaceuticals, Inc.1 co-mentions · 1 sources
- companyHikma Pharmaceuticals Plc1 co-mentions · 1 sources
indications
investigational
Major Depression
all catalysts(6)
approval · 6
Mar 16, 2006
approval
LORAZEPAM — FDA approval
lorazepam ER
→
Sep 8, 2010
approval
LORAZEPAM — FDA approval
lorazepam ER
→
Mar 26, 2025
approval
LORAZEPAM — FDA approval
lorazepam ER
→
Mar 26, 2025
approval
LORAZEPAM — FDA approval
lorazepam ER
→
Mar 26, 2025
approval
LORAZEPAM — FDA approval
lorazepam ER
→
Jan 5, 2026
approval
LORAZEPAM — FDA approval
lorazepam ER
→
Trials studying lorazepam ER
- phase4HPV Vaccine Reduced Dose
- —LORA-PITA IV General Investigation
- phase1Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg
- phase2Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose
- phase4Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 8, 2034
~7.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Jan 8, 2034formulationUS 8999393
- Jan 8, 2034formulationUS 8999393
- Jan 8, 2034formulationUS 8999393
- Jan 8, 2034formulationUS 8999393
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 33m ago
Found something off?
comments(0)
5-min edit window · permanent after that